Target
Payments companies reported to CMS as associated with Target. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Target, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Target
These are the largest totals companies reported as associated with Target. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Coon | Baltimore, MD | Neurological Surgery | $47,333.79 |
| Ansaar Rai | Morgantown, WV | Neuroradiology | $45,686.22 |
| Jan-Karl Burkhardt | New York, NY | Neurological Surgery | $44,752.53 |
| Geoffrey Colby | Los Angeles, CA | Neurological Surgery | $37,204.79 |
| Santiago Ortega Gutierrez | Iowa City, IA | Vascular & Interventional Radiology | $36,436.42 |
| Donald Frei | Englewood, CO | Diagnostic Radiology | $25,633.45 |
| Jonathan Lena | Charleston, SC | Neurological Surgery | $23,037.95 |
| Jared Knopman | New York, NY | Neurological Surgery | $20,442.70 |
| Italo Linfante | Miami, FL | Neuroradiology | $20,078.86 |
| Sudipta Roychowdhury | East Brunswick, NJ | Neuroradiology | $19,974.70 |
Prescribed Target?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.